Aotearoa Clinical Trials logo

Latest News

Maternal RSV Vaccine Approved by FDA

Maternal RSV Vaccine Approved by FDA

27/10/2023

Aotearoa Clinical Trials is proud to have been part of the MATISSE Trial. ABRYSVO™, Pfizer’s bivalent RSV preF vaccine for the prevention of Lower Respiratory Tract Disease (LRTD) and severe LRTD caused by RSV in infants from birth up to six months of age was approved by the FDA on 21st August 2023.

Read more
New Hospital partnership in Clinical Trials

New Hospital partnership in Clinical Trials

24/05/2023

Aotearoa Clinical Trials Trust is pleased to announce a partnership between Aotearoa Clinical Trials (ACTT) and Te Whatu Ora, Te Tai Tokerau for the management of clinical trials based at Whangarei Hospital for the community of Te Tai Tokerau Northland.

Read more
Study reveals recommended anticoagulant therapy for COVID patients

Study reveals recommended anticoagulant therapy for COVID patients

13/12/2022

The AustralaSian COVID-19 Trial (ASCOT) has pinpointed the most efficient level of blood thinning treatment needed for patients hospitalised with COVID-19, in a study published in the New England Journal of Medicine Evidence and presented at the American Society for Hematology conference today.

Read more